Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials
Haiting Huang(Affiliated Hospital of Youjiang Medical University for Nationalities), Xü Lin(First Affiliated Hospital Zhejiang University), Xintong Zheng(Affiliated Hospital of Youjiang Medical University for Nationalities), Xiuri Du(Affiliated Hospital of Youjiang Medical University for Nationalities), Zhiming Tang(Jiangsu University), Meili Wei(Affiliated Hospital of Youjiang Medical University for Nationalities), Qiuhong Zhong(Affiliated Hospital of Youjiang Medical University for Nationalities), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Qin(Mayo Clinic)
Cited by 0
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k